3 top healthcare shares on my shopping list

Although the healthcare sector has been one of the better performing areas of the market this year, I don’t think it is too late to gain exposure to it.

Three healthcare shares which I think would be great options for investors today are listed below. Here’s why I like them:

Greencross Limited (ASX: GXL)

This integrated pet care company’s shares currently change hands at just 16x trailing earnings. I think this is great value for a company growing at a solid rate in a weak consumer environment. For the first 16 weeks of FY 2018 Greencross reported a 5.4% increase in Australian Veterinary like-for-like sales and an 8.5% increase in group total sales. I believe the rollout of its in-store clinics will be a key driver of growth over the coming years. In-store clinics are currently found in 17% of its stores, but management is targeting over 60% in the future.

Medical Developments International Ltd (ASX: MVP)

Due to the global expansion of this healthcare company’s Penthrox pain management product, I believe Medical Developments International could be one to watch in 2018. The company is working towards making Penthrox the analgesic of choice around the world and I believe it has a great chance of succeeding. At present Penthrox is available in 16 countries worldwide, but over the next 12 months the company expects to have it approved for sale in more than 37 new countries. Its shares are expensive, though, so investors may want to wait for them to drop back a touch.

Nanosonics Ltd. (ASX: NAN)

Due to being regarded as best in class, environmentally friendly, and wholly effective at disinfecting ultrasound probes, this infection control specialist’s popular trophon EPR product has seen its installed base grow at a rapid rate over the last few years. Despite its strong growth, management estimates its share of the global market stands at just 12%. I expect it will continue to capture market share over the next few years and become increasingly profitable as it scales.

Finally, here are three blue-chips with growing dividends that I would buy today.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Greencross Limited and Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.